ArticleGalen medical journal2025
Effect of Innovative Low-level Laser Therapy Protocol for Stress Urinary Incontinence: A Case Series Study : Low-level Laser Therapy for Stress Urinary Incontinence.
Article in Galen medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Stress urinary incontinence (SUI) is a prevalent condition characterized by involuntary urine leakage during physical activities. This condition can significantly impact a woman's quality of life. Treatment options for SUI include behavioral therapy, medication, and surgery. However, non-pharmacological methods such as low-level laser therapy (LLT) have demonstrated the potential to promote tissue repair, reduce inflammation, and improve pelvic floor muscle function in various pelvic floor disorders. Despite these benefits, the effectiveness of combined transvaginal and intra-bladder LLT for managing SUI has not been extensively studied. This case series aimed to assess the safety and efficacy of a novel regimen using concurrent transvaginal and intra-bladder LLT for the treatment of stress urinary incontinence in perimenopausal and postmenopausal women. The results appear promising, and further investigation is recommended. Trial Registration: This clinical trial was registered in the Iranian Registry of Clinical Trials (IRCT) under the registration number IRCT20231203060255N2, on 30 June 2024 (retrospectively registered).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.